Hematuria screening: Difference between revisions
Jump to navigation
Jump to search
Adnan Ezici (talk | contribs) No edit summary |
Adnan Ezici (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for [[bladder cancer]] in patients with hematuria. | There is insufficient evidence to recommend routine screening for [[bladder cancer]] in patients with hematuria. However, according to the recently developed scoring system known as Haematuria Cancer Risk Score (HCRS), screening for bladder cancer in patients with hematuria with high HCRS score (based on age, sex, smoking history, and type of hematuria) might be recommended. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for [[bladder cancer]] in patients with hematuria. According to the U.S. Preventive Services Task Force (USPSTF), screening for bladder cancer in patients with hematuria is not recommended because of the insufficient evidence of benefit against harm. However, according to the recently developed scoring system known as Haematuria Cancer Risk Score (HCRS), screening for bladder cancer in patients with hematuria with high HCRS score (based on age | There is insufficient evidence to recommend routine screening for [[bladder cancer]] in patients with hematuria. | ||
*According to the U.S. Preventive Services Task Force (USPSTF), screening for bladder cancer in patients with hematuria is not recommended because of the insufficient evidence of benefit against harm. However, according to the recently developed scoring system known as Haematuria Cancer Risk Score (HCRS), screening for bladder cancer in patients with hematuria with high HCRS score (based on age, sex, smoking history, and type of hematuria) might be recommended.<ref name="IngelfingerLongo2021">{{cite journal|last1=Ingelfinger|first1=Julie R.|last2=Longo|first2=Dan L.|title=Hematuria in Adults|journal=New England Journal of Medicine|volume=385|issue=2|year=2021|pages=153–163|issn=0028-4793|doi=10.1056/NEJMra1604481}}</ref> | |||
==References== | ==References== | ||
Latest revision as of 14:09, 22 July 2021
|
Hematuria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hematuria screening On the Web |
|
American Roentgen Ray Society Images of Hematuria screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
There is insufficient evidence to recommend routine screening for bladder cancer in patients with hematuria. However, according to the recently developed scoring system known as Haematuria Cancer Risk Score (HCRS), screening for bladder cancer in patients with hematuria with high HCRS score (based on age, sex, smoking history, and type of hematuria) might be recommended.
Screening
There is insufficient evidence to recommend routine screening for bladder cancer in patients with hematuria.
- According to the U.S. Preventive Services Task Force (USPSTF), screening for bladder cancer in patients with hematuria is not recommended because of the insufficient evidence of benefit against harm. However, according to the recently developed scoring system known as Haematuria Cancer Risk Score (HCRS), screening for bladder cancer in patients with hematuria with high HCRS score (based on age, sex, smoking history, and type of hematuria) might be recommended.[1]
References
- ↑ Ingelfinger, Julie R.; Longo, Dan L. (2021). "Hematuria in Adults". New England Journal of Medicine. 385 (2): 153–163. doi:10.1056/NEJMra1604481. ISSN 0028-4793.